Aladdin education: strategic and regulatory science in paediatric oncology

ALADDIN is an educational program that aims to advance expertise and promote authentic multi-stakeholder collaboration in pediatric oncology drug development. It offers individuals from different disciplines the opportunity to learn how to navigate regulatory science effectively in the context of pediatric cancer drug development.

• Tailored for pediatric oncologists, pharmacists, and patient advocates

• 2-year program with 6 modules, each led by a different stakeholder

• For junior and senior researchers

• Engage in 3-6 month rotations at EMA and/or pharmaceutical companies

• Designed for advanced junior researchers

• Spanning 12 months with potential links to PhD programs

If you want to apply for the fellowship or join the webinars, you must subscribe to the ALADDIN portal.